| Income Statement |
| Total Revenue | 897.00M |
|
| Revenues (USD) | 897.00M |
| Cost of Revenue | 196.00M |
| Gross Profit | 701.00M |
| Operating Expenses | 698.00M |
| Research and Development Expense | 114.00M |
| Selling, General and Administrative Expense | 547.00M |
| Operating Income | 3.00M |
| Income Tax Expense | 9.00M |
| Net Income | 3.00M |
| Net Income Common Stock | 3.00M |
| Net Income Common Stock (USD) | 3.00M |
| Consolidated Income | 3.00M |
| Earnings per Basic Share | 0.01 |
| Earnings per Basic Share (USD) | 0.01 |
| Earnings per Diluted Share | 0.01 |
| Earning Before Interest & Taxes (EBIT) | 12.00M |
| Earning Before Interest & Taxes (USD) | 12.00M |
| Weighted Average Shares | 413.00M |
| Weighted Average Shares Diluted | 414.00M |
| Balance Sheet |
| Cash and Equivalents | 1.32B |
| Cash and Equivalents (USD) | 1.32B |
| Trade and Non-Trade Receivables | 269.00M |
| Current Assets | 1.71B |
| Property, Plant & Equipment Net | 1.49B |
| Total Assets | 10.16B |
| Debt Current | 28.00M |
| Total Debt | 1.19B |
| Current Liabilities | 777.00M |
| Debt Non-Current | 1.16B |
| Total Liabilities | 2.21B |
| Shareholders Equity | 7.91B |
| Shareholders Equity (USD) | 7.91B |
| Assets Non-Current | 8.46B |
| Total Debt (USD) | 1.19B |
| Deferred Revenue | 237.00M |
| Goodwill and Intangible Assets | 6.71B |
| Liabilities Non-Current | 1.44B |
| Trade and Non-Trade Payables | 381.00M |
| Tax Assets | 62.00M |
| Tax Liabilities | 275.00M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 90.00M |
| Net Cash Flow from Financing | -514.00M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -417.00M |
| Capital Expenditure | -54.00M |
| Issuance (Purchase) of Equity Shares | -513.00M |
| Net Cash Flow from Investing | -54.00M |
| Net Cash Flow from Operations | 152.00M |
| Effect of Exchange Rate Changes on Cash | -1000.00K |
| Share Based Compensation | 42.00M |